Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis (Q78124780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

Hellmich B

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Schnabel A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Gross WL

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

1752-1756

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446877%20AND%20SRC:MED&resulttype=core&format=json

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Wegener Granulomatosis: An Analysis of 158 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Infectious complications of cyclophosphamide treatment for vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Cutaneous vasculitis associated with granulocyte colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Drugs associated with vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Granulocyte-macrophage colony-stimulating factor and vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Differential effects of granulocyte‐ and granulocyte‐macrophage colony‐stimulating factors (G‐ and GM‐CSF) on neutrophil adhesion in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1752%3A%3AAID-ANR26%3E3.0.CO%3B2-6

10.1002/1529-0131(199908)42:8<1752::AID-ANR26>3.0.CO;2-6

21 January 2018

Identifiers

DOI

0 references

1 reference